Andrew W. Harris

Andrew W. Harris

Auto-generated profile, based on publicly available information

Andrew W. Harris

Department of Internal Medicine, Division of Cardiovascular Medicine, Michigan Medicine , Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in JACC: Advances
Verified
Journal Article
Open access
IKIbrahim Khaleel
Ibrahim Khaleel
AHAndrew W. Harris
Andrew W. Harris
MSMilan Seth
Milan Seth
DSDevraj Sukul
Devraj Sukul
GDG. Michael Deeb
G. Michael Deeb
SCStanley Chetcuti
Stanley Chetcuti
Prior studies of aortic valve replacement (AVR) in patients with normal-flow, low-gradient aortic stenosis (NF-LG AS) have demonstrated conflicting results regarding the survival benefit of AVR. Changes in quality of life (QoL) after transcatheter AVR (TAVR) have not been reported in this population. The purpose of this study was to compare changes in QoL after TAVR for patients with NF-LG AS to patients with high-gradient aortic stenosis (HG-AS). Patients who underwent TAVR for severe aortic stenosis (AS) were divided into 4 hemodynamic profiles of AS, including NF-LG AS. Changes in Kansas City Cardiomyopathy Questionnaire-12 score from baseline to 1 year were compared between AS groups. The primary composite outcome indicating clinical improvement consisted of survival to 1 year and improved Kansas City Cardiomyopathy Questionnaire overall summary score of ≥5 points while adjusting for relevant baseline factors. Out of 860 patients who underwent TAVR, high gradient AS was present in 368 (42.8%) patients and NF-LG AS in 245 (28.5%). HG-AS and NF-LG AS groups had a similar proportion of patients who met the primary unadjusted outcome of clinical improvement (70.4% vs 63.9%, respectively; P = 0.189). One-year Kaplan-Meier mortality estimates were higher for NF-LG AS patients than HG-AS patients (12.9% vs 5.8%, P < 0.001). In the primary adjusted analysis, there was no significant difference in the composite outcome between HG and NF-LG AS groups (adjusted OR: 0.72, 95% CI: 0.47-1.11). Selected patients with NF-LG AS experienced similar improvement in QoL after TAVR compared with HG-AS. Further investigation of patients with NF-LG AS will help to inform optimal selection for treatment with TAVR.

5 January 2025 in Structural Heart
Verified
Journal Article
Open access
CBCollin J. Brooks
Collin J. Brooks
NDNeal Duggal
Neal Duggal
MSMilan Seth
Milan Seth
MJMegan S. Joseph
Megan S. Joseph
DSDevraj Sukul
Devraj Sukul
AHAndrew W. Harris
Andrew W. Harris
There is a high prevalence of significant tricuspid regurgitation (TR) in patients undergoing mitral transcatheter edge-to-edge repair (M-TEER). Significant TR is associated with poor prognosis and affects decision-making between M-TEER and concomitant mitral and tricuspid valve surgery. Improved quality of life (QoL) is an important metric for patients. We analyzed data from 1838 patients undergoing M-TEER included in a multicenter statewide registry from 2015 to 2023. QoL was assessed using baseline and 30-day Kansas City Cardiomyopathy Questionnaire (KCCQ) scores. Patients were classified as no/mild TR or moderate/severe TR, and changes in KCCQ scores were compared. The primary outcome was an adjusted analysis consisting of survival to 30 days with a ≥15-point improvement in KCCQ score. Complete endpoint data were available for 1421 patients (77.3%). On average, patients undergoing M-TEER experienced large improvements in QoL, regardless of baseline TR group. Thirty-day mortality for patients with moderate/severe TR was higher than for those with no/mild TR (42 [4.1%] vs. 16 [2.0%], respectively, p ​= ​0.018). The majority of patients survived to 30 days with ΔKCCQ ≥15 (63.8% for no/mild TR vs. 59.6% for moderate/severe TR, p ​= ​0.120). Patients with moderate/severe TR exhibited no difference in the primary adjusted outcome (adjusted odds ratio: 0.851, p ​= ​0.177). The majority of patients experience a large improvement in QoL after M-TEER, regardless of baseline TR severity. Further research should explore a staged approach of M-TEER followed by tricuspid valve intervention as needed compared to concomitant mitral/tricuspid valve surgery.

1 September 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
JCJuan Caceres
Juan Caceres
MEMark Edwards
Mark Edwards
SKSarah Kurz
Sarah Kurz
BHBarbara C S Hamilton
Barbara C S Hamilton
CMChaitanya Madamanchi
Chaitanya Madamanchi
AHAndrew W Harris
Andrew W Harris
Background: Despite advances in echocardiography, the definitive diagnosis of prosthetic valve endocarditis (PVE) remains difficult. 18F-fluorodeoxyglucose (chemical name 2-deoxy-2-[18F]fluro-D-glucose) positron emission tomography (PET) shows promise with improved sensitivity. Our study explored the effects of PET findings on the diagnosis of PVE and patient management decisions. Method: Between 2016 and 2022, 140 patients underwent PET to evaluate suspected left-sided PVE, resulting in 93 patients with positive PET (+PET) and 47 patients with negative PET. Patients were classified as definite, possible, or rejected PVE according to the 2023 Duke-International Society for Cardiovascular Infectious Diseases guidelines, initially excluding and then including PET results. We evaluated the association between PET results and clinical outcomes such as duration of antibiotics, performance of cardiac surgery within 3 months, and long-term mortality. A qualitative analysis of medical decision-making was performed. Results: Demographics were similar between groups. patients with +PET had higher C-reactive protein levels (9.8 vs 3.1 mg/L, P = .001) and were more likely to have positive blood culture and echocardiographic findings. The addition of PET significantly increased the diagnosis of definite endocarditis (46%–63%, P < .001). A +PET was positively associated with ongoing use of antibiotics after 3 months (odds ratio [OR] 3.93, P = .002) and surgical management (OR 5.99, P = .008). Based on qualitative review of medical decision-making, PET influenced management in 88 patients (63%), supporting longer duration of antibiotics in 22%, surgical management in 8.6%, and shorter duration of antibiotics in 11% of patients. Conclusions: Positron emission tomography results, when incorporated into multidisciplinary discussion, aided in a more definitive diagnosis of PVE and influenced management in the majority of patients.

21 August 2025 in Cardiology Clinics
Verified
Journal Article
Closed access
MJMegan S. Joseph
Megan S. Joseph
AHAndrew W. Harris
Andrew W. Harris

15 January 2025 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
JCJuan Caceres
Juan Caceres
ASAbdulbaset Sulaiman
Abdulbaset Sulaiman
MEMark Edwards
Mark Edwards
SZShiwei Zhou
Shiwei Zhou
SKSarah Kurz
Sarah Kurz
AHAndrew W Harris
Andrew W Harris
Background: While echocardiography and cardiac positron emission tomography (PET) can aid in the diagnosis of prosthetic valve endocarditis (PVE), post-operative changes can lead to false-positive imaging findings. We report a case of a patient with an aortic valve prosthesis with remnant BioGlue deposits mimicking a para-valvular abscess on imaging in the setting of suspected PVE. Case summary: A 67-year-old man presented with 2 days of fever, chills, and altered mentation. He had a history of two prior aortic root replacements—19 and 4 years prior to his presentation. He had blood cultures that were persistently positive for Pseudomonas aeruginosa. Initial transoesophageal echocardiogram (TEE) was notable for a thickening of the posterior aortic root thought to be consistent with post-surgical changes. Cardiac PET showed significant uptake around the prosthetic aortic valve, concerning for a para-valvular abscess. However, given the patient’s high risk for re-do surgery, clearance of blood cultures, and preserved valve function, our multi-disciplinary endocarditis team (MET) recommended non-surgical management and close follow-up. After 6 weeks of appropriate antibiotics, a TEE demonstrated concern for an evolving para-valvular abscess. The MET performed extensive review of his prior surgical interventions and cardiac imaging, revealing the previous use of surgical BioGlue and stability in the aortic root on imaging, consistent with non-infectious post-surgical changes, and conservative management was recommended. Discussion: Thorough review of prior interventions and serial imaging in patients with suspected PVE through a multi-disciplinary team approach is essential in elucidating the complete, often complex, clinical picture and recommending the most appropriate management.

19 October 2026 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Open access
DCDakota De Cecco
Dakota De Cecco
CSChristopher Scoma
Christopher Scoma
CPCorey Powell
Corey Powell
MJMegan Joseph
Megan Joseph
WTWilliam Truesdell
William Truesdell
AHAndrew W. Harris
Andrew W. Harris